Drug Shortage Report for FOQUEST
Report ID | 151791 |
Drug Identification Number | 02470357 |
Brand name | FOQUEST |
Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE (CONTROLLED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-01-07 |
Actual start date | 2022-01-05 |
Estimated end date | 2024-08-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v41 | 2022-10-07 | French | Compare |
v42 | 2022-10-13 | English | Compare |
v43 | 2022-10-13 | French | Compare |
v44 | 2022-10-20 | English | Compare |
v45 | 2022-10-20 | French | Compare |
v46 | 2022-10-27 | English | Compare |
v47 | 2022-10-27 | French | Compare |
v48 | 2022-11-07 | English | Compare |
v49 | 2022-11-07 | French | Compare |
v50 | 2022-11-10 | English | Compare |
v51 | 2022-11-10 | French | Compare |
v52 | 2022-11-14 | English | Compare |
v53 | 2022-11-14 | French | Compare |
v54 | 2022-11-17 | English | Compare |
v55 | 2022-11-17 | French | Compare |
v56 | 2022-11-28 | English | Compare |
v57 | 2022-11-28 | French | Compare |
v58 | 2022-12-02 | English | Compare |
v59 | 2022-12-02 | French | Compare |
v60 | 2022-12-09 | English | Compare |